Compositions and methods using antiCS1 antibodies to treat multiple myeloma

Details for Australian Patent Application No. 2007281682 (hide)

International Classifications

Event Publications

5 March 2009 PCT application entered the National Phase

PCT publication WO2008/019376 Priority application(s): WO2008/019376

22 October 2009 Assignment before Grant

PDL BioPharma, Inc. The application has been assigned to Facet Biotech Corporation

3 February 2011 Alteration of Name

The name of the applicant has been altered to Abbott Biotherapeutics Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.